For more than a month in 2015, a multidisciplinary team including infectious disease and critical care physicians and nurses, respiratory therapists and other specialists at the National Institutes of Health (NIH) treated ...
Apr 4, 2016
0
12
The Democratic Republic of Congo is investigating a suspected case of Ebola in its violence-wracked east, the World Health Organization said Saturday, just weeks after the end of a previous epidemic.
Aug 21, 2022
0
26
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer—elements of the Ebola virus.
Feb 12, 2020
0
98
An interdisciplinary team of scientists at Duke University has developed a highly sensitive and rapid diagnostic test for Ebola virus (EBOV) infection. In monkeys infected with Ebola, this diagnostic, called the D4-assay, ...
Apr 7, 2021
0
23
In an article which appeared in The New England journal of Medicine on 16 April, researchers from Inserm (Jean Mérieux-Inserm BSL-4 Laboratory, Lyon) and the Institut Pasteur have published their initial findings on the ...
Apr 22, 2014
0
0
Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).
Jan 30, 2023
0
47
The Democratic Republic of Congo on Sunday confirmed its two first cases of Ebola this year, but claimed they were unrelated to the epidemic raging in four countries of West Africa.
Aug 24, 2014
0
0
Survivors of Ebola virus disease (EVD) in Liberia had a higher prevalence of certain health issues—including uveitis (eye redness and pain), abdominal, chest, neurologic, and musculoskeletal abnormalities upon physical ...
Mar 7, 2019
0
1
Researchers from The University of Texas Medical Branch at Galveston and Tekmira Pharmaceuticals Corp., have successfully developed a post-exposure treatment that is effective against a specific strain of the Ebola virus ...
Apr 22, 2015
0
107
Discoveries from the Benaroya Research Institute at Virginia Mason (BRI) have identified a new cellular protection pathway that targets a common vulnerability in several different pandemic viruses, and collaborators at Case ...
Aug 27, 2020
0
102
